INTRODUCTION AND OBJECTIVES: Despite the increasing availability of effective conventional medical treatments, plant-derived and herbomineral remedies continue to be a popular alternative for men seeking to improve sexual function. The aim of this study was to investigate the efficacy and safety of a mixed extract of Trigonella foenum-graecum seed and Lespedeza cuneata (TFGL) for the treatment of testosterone deficiency syndrome (TDS.
METHODS: Patients were instructed to take a placebo or 200 mg TFGL capsule twice per day for 8 weeks. The primary efficacy variable was the change from baseline in the Aging Males' Symptoms scale (AMS), as well as levels of serum total and free testosterone. Secondary efficacy measurements included changes from baseline in the number of 'yes' answers on the Androgen Deficiency in the Aging Male (ADAM) questionnaire, levels of serum total cholesterol, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), triglyceride, all domain scores of the International Index of Erectile Function (IIEF), perceived stress scale-10 (PSS-10), as well as changes in body composition.
RESULTS: The TFGL group exhibited a significant improvement in the AMS scores at 8 weeks, total testosterone at 8 weeks, and free testosterone at 4 and 8 weeks. At 4 weeks, 25% of the TFGL group changed to negative in terms of ADAM scores and 34.1% of the TFGL group had negative scores at the end of the study. The TFGL group exhibited a significant improvement in total cholesterol, HDL-C, LDL-C, triglyceride, IIEF scores, and PSS-10 scores at 8 weeks.
CONCLUSIONS: The mixed extract of TFGL resulted in significant improvements in symptoms of TDS, as measured by the AMS, ADAM, PSS-10 and testosterone levels. 
INTRODUCTION AND OBJECTIVES:
While it is common practice among surgeons to prescribe antibiotics after urethroplasty, it is unclear if this provides any benefit regarding patient options. Our objective was to evaluate infection and recurrence rates after single stage urethroplasty stratified by the use of postoperative antibiotics and to provide recommendations for best practices based on our experience with a diverse cohort.
METHODS: Retrospective chart review of men with a history of single stage urethroplasty from 2011 to 2017 based on hospital coding data. The procedures were performed by three surgeons at a single academic institution. Primary outcomes that were reviewed included: post-operative antibiotic prophylaxis, post-operative infection, and stricture recurrence requiring intervention of any type.
RESULTS: 160 men were identified with a mean age of 47 AE 15.8 years, and 30% of the cohort was African-American. Mean followup was 1 year (AE 1.3 years). All patients received preoperative antibiotic prophylaxis. Post-operatively, 97/160 (60.6%) patients received prophylactic antibiotics and 63/160 (39.4%) did not. At initial followup, patients who received antibiotics at discharge were routinely cultured prior to foley catheter removal, while the non-antibiotic patients were only selectively cultured if symptomatic. Positive urine cultures (defined as the presence of any growth of bacteria/fungi) were noted in 36/160 (22.5%) patients. Of the 36 with positive cultures, 26 (72.2%) had received antibiotics at discharge, while 10 (27.8%) had not. Despite receiving antibiotics at discharge, 26/97 (26.8%) had a positive urine culture postop. Among the 14 men with symptomatic urinary tract infections, 9 had received antibiotics at time of discharge from surgery. Men who had a positive urine culture at initial follow-up were significantly more likely to develop disease recurrence (30.6% vs 15.3%, p [ 0.04), though culture was not routinely done in the non-antibiotic group, perhaps missing some positive cultures. There were 30/160 (20%) symptomatic urethral stricture recurrences. 17/30 men with stricture recurrence received antibiotics at discharge vs 13/30 men who did not (56.7% vs 43.3%, p[0.62) .
CONCLUSIONS: Despite receiving post-operative antibiotic prophylaxis after urethroplasty, 26.8% of men still have positive urine cultures. Furthermore, postoperative antibiotic use did not reduce symptomatic stricture recurrence rate. Routine antibiotic prescription after urethroplasty should be abandoned.
Source of Funding: None

PD22-02 A MULTICENTER ASSESSMENT OF STRICTURE LOCATION AND TYPE OF URETHROPLASTY ON ERECTILE FUNCTION
INTRODUCTION AND OBJECTIVES: Urethroplasty has been associated with erectile dysfunction (ED), likely due to the close proximity of the cavernous neurovascular bundle to the membranous and bulbar urethra. The relationship between erectile dysfunction and stricture location is under-reported. We hypothesize that more proximal stricture locations would be associated with erectile dysfunction.
METHODS: We performed a retrospective review of urethroplasty data from 8 participating centers in the Trauma and Urologic Reconstruction Network of Surgeons. We excluded men with prior pelvic radiation or pelvic fracture urethral injuries. Erectile function was measured using the Sexual Health Inventory for Men (SHIM) pre-and post-operatively. Stricture location was classified as membranous, proximal bulbar, or mid/distal bulbar. Type of urethroplasty was classified as anastomotic or other. A clinically significant change in erectile function was defined as a SHIM change of ! or 5.
RESULTS: There were 1137 patients who met inclusion criteria. Median age was 45.1 years (IQR 32.9-56.7). Median follow up time to first and last post-op visits were 3.7 (IQR 3.4-4.3) and 12.8 (IQR 6.3-24.1) months, respectively. The mean SHIM scores stratified by stricture location and type of repair are listed in Table 1 . Patients had mild preoperative ED without a significant change in erectile function at time of last follow up visit. Of the 365 patients with more than one post-operative visit, 51 patients (14.0%) had a clinically significant worsening of erectile function while 26 patients (7.1%) had an improvement in erectile function.
CONCLUSIONS: Urethral stricture patients have mild baseline erectile dysfunction. Stricture location or anastomotic repairs are not associated with worsening erectile function Further research is needed to identify those patients who will experience a clinically significant reduction in erectile function.
